- Resource
- Source: Campus Sanofi
- 1 Nov 2024
Praluent® (alirocumab) - Comprehensive Support for the Praluent® Patient
Disclaimer: The resources contained within this section are updated regularly by Sanofi. Before you use any of the resources, or provide any resources to your patients please re-visit this page to ensure that you are using the most up-to-date version(s).
Patient Resources
RESOURCES FOR PRALUENT® 75MG OR 150MG
▶ Digital Starter Pack (PDF)
▶ Praluent® Injection Guide (PDF)
▶ Living with High Cholesterol (PDF)
▶ Digital Starter Pack (PDF)
▶ Praluent® Injection Guide (PDF)
▶ Living with High Cholesterol (PDF)
▶ How to Inject Praluent® (video)
RESOURCES FOR PRALUENT® 300MG
▶ Digital Starter Pack (PDF)
▶ Praluent® Injection Guide (PDF)
▶ Living with High Cholesterol (PDF)
▶ Digital Starter Pack (PDF)
▶ Praluent® Injection Guide (PDF)
▶ Living with High Cholesterol (PDF)
▶ How to Inject Praluent® (video)
Patient Profiles
Homecare
References
- Schwartz G, et al. N Engl J Med 2018;379(22):2097–2107.
MAT-XU-2204602 (v8.0) Date of Preparation: November 2024